Paul R Kirchgraber - Net Worth and Insider Trading

Paul R Kirchgraber Net Worth

The estimated net worth of Paul R Kirchgraber is at least $2 Million dollars as of 2023-03-28. Paul R Kirchgraber is the CEO, Covance Drug Development of Laboratory Corp of America Holdings and owns about 7,844 shares of Laboratory Corp of America Holdings (LH) stock worth over $2 Million. Details can be seen in Paul R Kirchgraber's Latest Holdings Summary section.

Transaction Summary of Paul R Kirchgraber

To

Paul R Kirchgraber Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul R Kirchgraber owns 1 companies in total, including Laboratory Corp of America Holdings (LH) .

Click here to see the complete history of Paul R Kirchgraber’s form 4 insider trades.

Insider Ownership Summary of Paul R Kirchgraber

Ticker Comapny Transaction Date Type of Owner
LH Laboratory Corp of America Holdings 2019-11-01 CEO & Covance Drug Development

Paul R Kirchgraber Latest Holdings Summary

Paul R Kirchgraber currently owns a total of 1 stock. Paul R Kirchgraber owns 7,844 shares of Laboratory Corp of America Holdings (LH) as of May 6, 2021, with a value of $2 Million.

Latest Holdings of Paul R Kirchgraber

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LH Laboratory Corp of America Holdings 2021-05-06 7,844 219.78 1,723,954

Holding Weightings of Paul R Kirchgraber


Paul R Kirchgraber Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul R Kirchgraber has made a total of 2 transactions in Laboratory Corp of America Holdings (LH) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Laboratory Corp of America Holdings is the sale of 2,500 shares on May 6, 2021, which brought Paul R Kirchgraber around $691,375.

Insider Trading History of Paul R Kirchgraber

Ticker
Company
Date
Buy/Sell
Insider Trading Shares
Shares Change
Price
Cost
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
LH
Laboratory Corp of America Holdings
2021-05-06
Sell
2,500.00
-24.17%
$276.55
$691,375.00
7,844.00
$219.78
-20.53%
-
LH
Laboratory Corp of America Holdings
2020-11-04
Sell
1,500.00
-16.31%
$214.14
$321,210.00
7,698.00
$219.78
2.63%
-
Total 2
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul R Kirchgraber Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Paul R Kirchgraber Ownership Network

Ownership Network List of Paul R Kirchgraber

No Data

Ownership Network Relation of Paul R Kirchgraber


Paul R Kirchgraber Owned Company Details

What does Laboratory Corp of America Holdings do?

Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Who are the key executives at Laboratory Corp of America Holdings?

Paul R Kirchgraber is the CEO & Covance Drug Development of Laboratory Corp of America Holdings. Other key executives at Laboratory Corp of America Holdings include Pres & CEO Clinical Business Thomas Pike , EVP & Chief Marketing Officer Amy B. Summy , and EVP & President-Diagnostics Lab Mark S Schroeder .

Laboratory Corp of America Holdings (LH) Insider Trades Summary

Over the past 18 months, Paul R Kirchgraber made no insider transaction in Laboratory Corp of America Holdings (LH). Other recent insider transactions involving Laboratory Corp of America Holdings (LH) include a net sale of 4,879 shares made by Mark S Schroeder , a net sale of 3,231 shares made by Van Der Vaart Sandra D , and a net sale of 57,100 shares made by Glenn A Eisenberg .

In summary, during the past 3 months, insiders sold 1,434 shares of Laboratory Corp of America Holdings (LH) in total and bought 0 shares, with a net sale of 1,434 shares. During the past 18 months, 68,607 shares of Laboratory Corp of America Holdings (LH) were sold and 3,586 shares were bought by its insiders, resulting in a net sale of 65,021 shares.

Laboratory Corp of America Holdings (LH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Laboratory Corp of America Holdings Insider Transactions

20/Page
Total 0
Ticker
Insider
Position
Date
Buy/Sell
Shares
Shares Owned
Trade Price($)
Trade Percentage(%)
Cost($1000)
Price change since trade(%)
Share ownership details
Filing Date
20/Page
Total 0

Paul R Kirchgraber Mailing Address

Above is the net worth, insider trading, and ownership report for Paul R Kirchgraber. You might contact Paul R Kirchgraber via mailing address: 531 South Spring Street, Burlington Nc 27215.